Robert Gniadecki

Professor

Bispebjerg Hospital

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert Gniadecki is a Professor at Bispebjerg Hospital in Denmark. His research focuses on dermatological conditions, including systemic sclerosis, psoriasis, and cutaneous T-cell lymphoma. He has contributed significantly to the understanding of skin cancer risk factors and the treatment of mycosis fungoides and Sézary syndrome. His recent publications also explore mitochondrial dysfunction and the implications of systemic therapies in dermatology.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Aishwarya Iyer

University of Alberta

CANADA

View details

Oleg Akilov

Assistant Professor

University of Pittsburgh School of Medicine

UNITED STATES

View details

Emmanuella Guenova

University of Zurich

SWITZERLAND

View details

Melinda J. Gooderham

CANADA

View details

Ivan V. Litvinov

McGill University Health Centre

CANADA

View details

Douwe Johannes Mulder

University Medical Center Groningen

NETHERLANDS

View details

jan willem cohen tervaert

Emeritus Professor

University of Maastricht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Gniadecki

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Transcriptomic skin niches in systemic sclerosis underpin a role for mitochondrial dysfunction

Merkel cell carcinoma in a psoriasis patient on long-term ixekizumab therapy: A case report

Should Calcium Supplementation be Abandoned in Patients With Calcinosis Cutis?

Two case reports of MDA5-type seronegative dermatomyositis

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – update 2023

Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel

Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study

Methods of Assessing Nailfold Capillaroscopy Compared to Video Capillaroscopy in Patients with Systemic Sclerosis—A Critical Review of the Literature

Is Cutaneous T-Cell Lymphoma Caused by Ultraviolet Radiation? A Comparison of UV Mutational Signatures in Malignant Melanoma and Mycosis Fungoides

Clonotype pattern in T-cell lymphomas map the cell of origin to immature lymphoid precursors

Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma

Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel

Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real‐world evidence study

Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage—A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis

Collaborators (7)

Aishwarya Iyer

Oleg Akilov

Emmanuella Guenova

Melinda J. Gooderham

Ivan V. Litvinov

Douwe Johannes Mulder

jan willem cohen tervaert

Make your next move.